Fecal microbiota transplantation in metabolic syndrome: History, present and future

P. F. de Groot, M. N. Frissen, N. C. de Clercq, M. Nieuwdorp

Research output: Contribution to journalReview articleAcademicpeer-review

205 Citations (Scopus)


The history of fecal microbiota transplantation (FMT) dates back even to ancient China. Recently, scientific studies have been looking into FMT as a promising treatment of various diseases, while in the process teaching us about the interaction between the human host and its resident microbial communities. Current research focuses mainly on Clostridium difficile infections, however interest is rising in other areas such as inflammatory bowel disease (IBD) and the metabolic syndrome. With regard to the latter, the intestinal microbiota might be causally related to the progression of insulin resistance and diabetes. FMT in metabolic syndrome has proven to be an intriguing method to study the role of the gut microbiota and open the way to new therapies by dissecting in whom insulin resistance is driven by microbiota. In this article we review the history of FMT, the present evidence on its role in the pathophysiology of metabolic syndrome and its efficacy, limitations and future prospects.

Original languageEnglish
Pages (from-to)253-267
Number of pages15
JournalGut Microbes
Issue number3
Publication statusPublished - 4 May 2017


  • fecal transplantation
  • metabolic syndrome
  • microbiota

Cite this